EXTAVIA (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the EXTAVIA drug offered from Novartis Pharmaceuticals Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | Interferon beta-1b |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-08-14 |
| END MARKETING DATE: | 0000-00-00 |
EXTAVIA HUMAN PRESCRIPTION DRUG Details:
| Item Description | EXTAVIA from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2009-08-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0569_ccbcd313-1b72-4f00-882a-559a002136bf |
| PRODUCT NDC: | 0078-0569 |
| APPLICATION NUMBER: | BLA125290 |